Search Results - "CAI, MENGYIN"

Refine Results
  1. 1

    The many faces of diabetes: a disease with increasing heterogeneity by Tuomi, Tiinamaija, MD, Santoro, Nicola, MD, Caprio, Sonia, Prof, Cai, Mengyin, MD, Weng, Jianping, Prof, Groop, Leif, Prof

    Published in The Lancet (British edition) (22-03-2014)
    “…Summary Diabetes is a much more heterogeneous disease than the present subdivision into types 1 and 2 assumes; type 1 and type 2 diabetes probably represent…”
    Get full text
    Journal Article
  2. 2

    Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney by De Marinis, Yang, Cai, Mengyin, Bompada, Pradeep, Atac, David, Kotova, Olga, Johansson, Martin E, Garcia-Vaz, Eliana, Gomez, Maria F, Laakso, Markku, Groop, Leif

    Published in Kidney international (01-02-2016)
    “…Diabetic kidney disease is the leading cause of end-stage renal disease. Genetic factors have been suggested to contribute to its susceptibility. However,…”
    Get more information
    Journal Article
  3. 3

    Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney by Cai, Mengyin, Bompada, Pradeep, Atac, David, Laakso, Markku, Groop, Leif, De Marinis, Yang

    “…Diabetes nephropathy (DN) is the leading cause of end stage renal disease and it affects up to 40% of diabetic patients. In addition to hyperglycemia, genetic…”
    Get full text
    Journal Article
  4. 4

    Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD by Cao, Huanyi, Cai, Qingxian, Guo, Wanrong, Su, Qiao, Qin, Hancheng, Wang, Tian, Xian, Yingxin, Zeng, Longyi, Cai, Mengyin, Guan, Haixia, Chen, Sifan, Liang, Hua, Xu, Fen

    Published in Cell reports (Cambridge) (25-04-2023)
    “…Protein post-translational modifications (PTMs) participate in important bioactive regulatory processes and therefore can help elucidate the pathogenesis of…”
    Get full text
    Journal Article
  5. 5

    Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis by Guo, Wanrong, Cao, Huanyi, Shen, Yunfeng, Li, Wuguo, Wang, Wei, Cheng, Lidan, Cai, Mengyin, Xu, Fen

    Published in Nutrition & diabetes (12-04-2024)
    “…Background The effectiveness of ketogenic diet (KD) in ameliorating fatty liver has been established, although its mechanism is under investigation. Fibroblast…”
    Get full text
    Journal Article
  6. 6

    Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice by ZHANG, YU, XU, FEN, LIANG, HUA, CAI, MENGYIN, WEN, XINQIAO, LI, XIAOMAO, WENG, JIANPING

    Published in Oncology reports (01-03-2016)
    “…Studies have showed that diabetes is one of the high risk factors of endometrial cancer; however, no reports describe the anti- or pro-cancer effect of a new…”
    Get full text
    Journal Article
  7. 7

    The SRE Motif in the Human PNPLA3 Promoter (−97 to −88 bp) Mediates Transactivational Effects of SREBP-1c by Liang, Hua, Xu, Jing, Xu, Fen, Liu, Hongxia, Yuan, Ding, Yuan, Shuhua, Cai, Mengyin, Yan, Jinhua, Weng, Jianping

    Published in Journal of cellular physiology (01-09-2015)
    “…Patatin‐like phospholipase domain containing 3 (PNPLA3) is a non‐secreted protein primarily expressed in liver and adipose tissue. Recently, numerous genetic…”
    Get full text
    Journal Article
  8. 8

    Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription by Bi, Yan, Wu, Wenjun, Shi, Junfeng, Liang, Hua, Yin, Wenwen, Chen, Yingying, Tang, Sunyinyan, Cao, Shu, Cai, Mengyin, Shen, Shanmei, Gao, Qian, Weng, Jianping, Zhu, Dalong

    Published in Diabetologia (01-03-2014)
    “…Aims/hypothesis Sterol regulatory element binding protein-1c (SREBP-1c) is a master regulator of fatty acid synthase and controls lipogenesis. IRS-1 is the key…”
    Get full text
    Journal Article
  9. 9

    Liraglutide protects against high-fat diet-induced kidney injury by ameliorating apoptosis by Liang, Riying, Wang, Meijun, Fu, Chang, Liang, Hua, Deng, Hongrong, Tan, Ying, Xu, Fen, Cai, Mengyin

    Published in Endocrine Connections (01-10-2020)
    “…Background: Obesity is associated with the development and progression of chronic kidney disease. Emerging evidence suggests that glucagon-like peptide-1…”
    Get full text
    Journal Article
  10. 10

    Insight into the biochemical characteristics of a novel glucokinase gene mutation by Shen, Yunfeng, Cai, Mengyin, Liang, Hua, Wang, Hongwei, Weng, Jianping

    Published in Human genetics (01-03-2011)
    “…Glucokinase (GCK) acts as a glucose sensor and regulates β-cell insulin secretion. The heterozygous mutations in the gene encoding GCK cause a reduction of the…”
    Get full text
    Journal Article
  11. 11

    Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate by Ye, Chunwei, Li, Xiaojuan, Wang, Yu, Zhang, Yuying, Cai, Mengyin, Zhu, Baoyi, Mu, Panwei, Xia, Xuan, Zhao, Yi, Weng, Jianping, Gao, Xin, Wen, Xingqiao

    Published in Laboratory investigation (01-09-2011)
    “…The molecular impact of diabetes mellitus on prostate gland has not been elucidated. In this study, we performed a whole-genome cDNA microarray analysis using…”
    Get full text
    Journal Article
  12. 12

    6q24 transient neonatal diabetes mellitus: the first case report from China by Yao, Bin, Zhang, Xinhan, Liang, Hua, Xu, Wen, Cai, Mengyin, Yan, Jinhua, Weng, Jianping

    Published in Chinese medical journal (2014)
    “…To the editor: Neonatal diabetes mellitus (NDM) is one kind of monogenic diabetes which usually presents within 6 months after birth and needs insulin…”
    Get full text
    Journal Article
  13. 13
  14. 14

    SIRT1/HSF1/HSP pathway is essential for exenatide‐alleviated, lipid‐induced hepatic endoplasmic reticulum stress by Zheng, Xiaobin, Xu, Fen, Liang, Hua, Cao, Huanyi, Cai, Mengyin, Xu, Wen, Weng, Jianping

    Published in Hepatology (Baltimore, Md.) (01-09-2017)
    “…Recent studies have indicated that lipid‐induced endoplasmic reticulum (ER) stress is a major contributor to the progression of hepatic steatosis. Exenatide…”
    Get full text
    Journal Article
  15. 15

    SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis by Shen, Yunfeng, Cheng, Lidan, Xu, Minxuan, Wang, Wei, Wan, Zhiping, Xiong, Haixia, Guo, Wanrong, Cai, Mengyin, Xu, Fen

    Published in Metabolism, clinical and experimental (01-09-2023)
    “…Activation of hepatic stellate cells (HSCs), the central event of fibrosis, indicates the severe stage of non-alcoholic fatty liver disease (NAFLD). MicroRNAs…”
    Get full text
    Journal Article
  16. 16

    1572-P: Lipotoxicity-Induced TET1 Mediates CD36 DNA Demethylation in Liver Macrophages to Aggravate NAFLD Progression by Yu, Piaojian, Xian, Yingxin, Cao, Huanyi, Deng, Xiaojie, Cai, Mengyin, Xu, Fen

    Published in Diabetes (New York, N.Y.) (01-06-2024)
    “…Aims: DNA methylation is dysregulated in nonalcoholic fatty liver disease (NAFLD), yet the dominant genes and regulatory mechanisms remain obscure. Here,…”
    Get full text
    Journal Article
  17. 17

    394-P: Empagliflozin Ameliorate Renal Fibrosis in DKD by Cai, Xiang, Cao, Huanyi, Wang, Meijun, Yu, Piaojian, Liang, Xiaoqi, Liang, Hua, Xu, Fen, Cai, Mengyin

    Published in Diabetes (New York, N.Y.) (01-06-2024)
    “…Introduction & Objective: Sodium-glucose cotransporter 2 (SGLT2) inhibitors improve renal outcomes in diabetic kidney disease (DKD), but the mechanisms…”
    Get full text
    Journal Article
  18. 18

    1784-LB: LRP5 Promotes Fatty Acid Oxidation through Enhancement of PPAR/PGC-1 Signaling in DKD with Dyslipidemia by He, Xuemin, Zhang, Rui, Wen, Siying, Xiang, Xiaoxin, Cai, Mengyin, Chen, Yanming

    Published in Diabetes (New York, N.Y.) (01-06-2024)
    “…Dyslipidemia is an independent risk factor for diabetic kidney disease (DKD), but some lipid-lowering drugs are reported to exacerbate this disease, as they…”
    Get full text
    Journal Article
  19. 19

    520-P: Exenatide Ameliorates Diabetic Kidney Disease by Inhibiting Apoptosis via SIRT1/TXNIP Signal Pathway by WANG, MEIJUN, LIANG, RIYING, XU, FEN, CAI, MENGYIN

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…Recent studies have indicated apoptosis to be a major contributor to the progression of Diabetic Kidney Disease. GLP-1 agonist such as Exenatide, which…”
    Get full text
    Journal Article
  20. 20

    1138-P: Empagliflozin Ameliorates Kidney Injury in Diabetic Nephropathy via SIRT1 and TXNIP by LIANG, RIYING, WANG, MEIJUN, XU, FEN, CAI, MENGYIN

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…SGLT2 inhibitor empagliflozin can slower the decline of eGFR and reduce the occurrence rate of end-stage kidney disease according to EMPA-REG OUTCOME Clinical…”
    Get full text
    Journal Article